Skip to main content
. 2011 Apr 21;17(1):18–26. doi: 10.1007/s12199-011-0214-1

Table 2.

Characteristics of the subjects by lung function status

Characteristics Normal lung function (n = 10,669) Airflow obstruction p
GOLD stage I (n = 452) GOLD stage II–IV (n = 466)
Age (years) 54.1 ± 8.9 61.2 ± 9.8 60.8 ± 9.6* <0.001
BMI (kg/m2) 23.8 ± 2.9 22.9 ± 2.5 23.2 ± 2.9* <0.001
FEV1 % predicted 95.6 ± 9.6 89.2 ± 7.7 66.7 ± 11.2*,# <0.001
FEV1/FVC (%) 79.7 ± 4.8 66.2 ± 2.9 62.2 ± 6.9*,# <0.001
Creatinine (mg/dL) 0.88 ± 0.31 0.87 ± 0.21 0.85 ± 0.14 0.17
Estimated GFR (mL/min/1.73 m2) 74.4 ± 12.9 72.8 ± 14.1 74.0 ± 13.9 <0.05
CRP (mg/L) 0.11 ± 0.36 0.13 ± 0.41 0.18 ± 0.41* <0.05
Hyper-LDL-cholesterolemia (%) 32.5 28.5 35.0 0.10
Hypertension (%) 30.7 32.3 39.9*,# <0.001
Diabetes (%) 9.9 7.5 12.7# 0.32
Medication
 Treatment for cholesterolemia (%) 8.0 8.0 13.1*,# <0.001
 Treatment for hypertension (%) 18.8 19.0 29.2*,# <0.001
 Treatment for diabetes (%) 5.1 3.8 7.7*,# <0.05
Chronic kidney disease (%) 10.2 14.4 14.8 <0.001
Smoking history (%) <0.001
 Never smokers 32.9 25.2 14.6
 Former smokers 37.9 40.3 38.4
 Current smokers 29.3 34.5* 47.0*
Pack-yearsa 17.5 ± 18.9 26.0 ± 23.9 37.5 ± 27.5*,# <0.001
Alcohol intake (%) <0.05
 Non-drinkers 23.5 23.9 30.9
 1–2 days/week 13.6 8.6 9.4
 3–4 days/week 11.5 8.2 6.9
 5–6 days/week 12.9 12.6 12.2
 Everyday drinkers 38.4 46.7* 40.6
Regular physical activitya (%) 35.2 45.6* 39.5# <0.001

*p < 0.05 compared with normal lung function; #p < 0.05 compared with GOLD stage I

Data were analyzed by analysis of variance (ANOVA) and post-hoc Tukey test or Kruskal–Wallis test and post-hoc Bonferroni adjustment. Values are presented as the mean and, where appropriate,  ± SD

GOLD Global Initiative for Chronic Obstructive Lung Disease guidelines [2]

aPack-years and Regular physical activity are as defined in the footnote to Table 1